TY  - GEN
AU  - Bergmann,L
AU  - Fenchel,K
AU  - Weidmann,E
AU  - Enzinger,H M
AU  - Jahn,B
AU  - Jonas,D
AU  - Mitrou,P S
TI  - Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study
SN  - 0008-543X
PY  - 1993///0916
KW  - Aged
KW  - Aged, 80 and over
KW  - Carcinoma, Renal Cell
KW  - blood
KW  - Drug Administration Schedule
KW  - Drug Combinations
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - administration & dosage
KW  - Interferon-gamma
KW  - Interleukin-2
KW  - Interleukin-6
KW  - Kidney Neoplasms
KW  - Leukocyte Count
KW  - Lymphocyte Subsets
KW  - pathology
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - therapy
KW  - Receptors, Interleukin-2
KW  - analysis
KW  - Recombinant Proteins
KW  - Remission Induction
KW  - T-Lymphocyte Subsets
KW  - Tumor Necrosis Factor-alpha
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/1097-0142(19930901)72:5<1733::aid-cncr2820720537>3.0.co;2-x
ER  -